Business Description
Rebus Hldgs Inc
NAICS : 325412
SIC : 2834
ISIN : US75619J1034
Description
Rebus Hldgs Inc is an early-stage, pre-revenue, pharmaceutical company that is focused on the development of prodrug cancer therapeutics for the treatment of disease. The company along with its subsidiaries is engaged in the production of small-molecule adenosine receptor modulators. Adenosine is an extracellular signaling molecule that regulates multiple aspects of tissue function and specifically plays a role in immunity and inflammation.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RBSH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rebus Hldgs Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.008 | ||
| Beta | -30.4056 | ||
| 3-Year Sharpe Ratio | -0.54 | ||
| 3-Year Sortino Ratio | -0.68 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0001 | ||
| Shares Outstanding (Mil) | 32.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rebus Hldgs Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rebus Hldgs Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.013333:1 Stock Split | 2021-10-12 | 0.20 (-18.18%) | ||
| 0.033333:1 Stock Split | 2020-06-30 | 6.75 (-33.33%) | ||
| 0.04:1 Stock Split | 2019-10-01 | 106.88 (-47.22%) | ||
| 0.033333:1 Stock Split | 2016-11-18 | 164,529.19 (+0.00%) |
Show
Entries
Rebus Hldgs Inc Frequently Asked Questions
What is Rebus Hldgs Inc(RBSH)'s stock price today?
The current price of RBSH is $0.00. The 52 week high of RBSH is $0.00 and 52 week low is $0.00.
When is next earnings date of Rebus Hldgs Inc(RBSH)?
The next earnings date of Rebus Hldgs Inc(RBSH) is .
Does Rebus Hldgs Inc(RBSH) pay dividends? If so, how much?
Rebus Hldgs Inc(RBSH) does not pay dividend.
Guru Commentaries on OTCPK:RBSH
No articles.
Press Release
Articles on Rebus Hldgs Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers